The State is spending more and more money on medicines. That’s because new medicines are often costly. And because people are living longer. The government makes agreements with doctors, pharmacists and health insurers to keep medicines affordable. The government is also responsible for monitoring the efficacy, quality and risks of medication.
© Hollandse Hoogte
Positive outcome of joint reimbursement negotiations on Spinraza
12-07-2018 | 07:00
Beneluxa Initiative partners Belgium and the Netherlands successfully negotiated the price of Spinraza Belgium and the...
Ireland joins Beneluxa initiative
22-06-2018 | 16:00
Today, the Irish Minister for Health, Simon Harris signed an Agreement with his colleagues from Belgium, The Netherlands,...
The Netherlands opens helpdesk for EMA staff in London
08-12-2017 | 17:05
As of today, the staff of the European Medicines Agency (EMA) in London can address any question they may have on their...